Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants

Sellares, 2012, Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, 12, 388, 10.1111/j.1600-6143.2011.03840.x Gaston, 2010, Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure, Transplantation, 90, 68, 10.1097/TP.0b013e3181e065de Zhang, 2009, Effect of antibodies on endothelium, Am J Transplant, 9, 2459, 10.1111/j.1600-6143.2009.02819.x Hirohashi, 2012, A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody, Am J Transplant, 12, 313, 10.1111/j.1600-6143.2011.03836.x Feucht, 1993, Capillary deposition of C4d complement fragment and early renal graft loss, Kidney Int, 43, 1333, 10.1038/ki.1993.187 Cohen, 2012, Pros and cons for C4d as a biomarker, Kidney Int, 81, 628, 10.1038/ki.2011.497 Sellares, 2013, Molecular diagnosis of antibody-mediated rejection in human kidney transplants, Am J Transplant, 13, 971, 10.1111/ajt.12150 Sis, 2009, Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining, Am J Transplant, 9, 2312, 10.1111/j.1600-6143.2009.02761.x Stuht, 2007, Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies, Am J Transplant, 7, 377, 10.1111/j.1600-6143.2006.01638.x Dietrich, 2010, Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation, J Immunol, 184, 535, 10.4049/jimmunol.0903180 Yin, 2011, Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival, Transplantation, 92, 25, 10.1097/TP.0b013e31821d2661 Bonsib, 2006, Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases, Mod Pathol, 19, 746, 10.1038/modpathol.3800589 Colvin, 1997, Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation, J Am Soc Nephrol, 8, 1930, 10.1681/ASN.V8121930 Solez, 2008, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x Haas, 2014, Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, 14, 272, 10.1111/ajt.12590 Hourmant, 2005, Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation, J Am Soc Nephrol, 16, 2804, 10.1681/ASN.2004121130 Rose, 1998, Endothelial cells as antigen-presenting cells: role in human transplant rejection, Cell Mol Life Sci, 54, 965, 10.1007/s000180050226 Trpkov, 1996, Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema, Transplantation, 61, 1586, 10.1097/00007890-199606150-00007 Colvin, 2007, Antibody-mediated renal allograft rejection: diagnosis and pathogenesis, J Am Soc Nephrol, 18, 1046, 10.1681/ASN.2007010073 Koskinen, 1997, Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat, Circulation, 95, 191, 10.1161/01.CIR.95.1.191 Izawa, 2007, Importance of donor- and recipient-derived selectins in cardiac allograft rejection, J Am Soc Nephrol, 18, 2929, 10.1681/ASN.2006111261 Sarraj, 2014, Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection, Proc Natl Acad Sci U S A, 111, 12145, 10.1073/pnas.1303676111 Langer, 2004, Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines, J Am Soc Nephrol, 15, 2893, 10.1097/01.ASN.0000142425.23036.AC Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Xu, 2007, Cutting edge: regulatory T cells induce CD4+CD25−Foxp3− T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta, J Immunol, 178, 6725, 10.4049/jimmunol.178.11.6725 Savage, 1991, Endothelial cell lymphocyte function–associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells, Cell Immunol, 137, 150, 10.1016/0008-8749(91)90065-J Adams, 1992, Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells, J Immunol, 148, 3753, 10.4049/jimmunol.148.12.3753 Page, 1994, Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathway, Transpl Immunol, 2, 342, 10.1016/0966-3274(94)90013-2 Murakami, 1999, Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA, J Immunol, 163, 2667, 10.4049/jimmunol.163.5.2667 Taflin, 2011, Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions, Proc Natl Acad Sci U S A, 108, 2891, 10.1073/pnas.1011811108 Kim, 2014, The clinical spectrum of de novo donor-specific antibodies in pediatric renal transplant recipients, Am J Transplant, 14, 2350, 10.1111/ajt.12859 Batal, 2010, A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies, Am J Transplant, 10, 2442, 10.1111/j.1600-6143.2010.03261.x Randhawa, 2015, T-cell–mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance, Curr Opin Organ Transplant, 20, 325, 10.1097/MOT.0000000000000189